Provasculon was founded to exploit the discovery by Richard Lee, MD, a cardiologist at Brigham and Women's Hospital and Associate Professor at Harvard Medical School, and Vincent Segers, MD, a researcher at Brigham and Women's Hospital, of forms of the growth factor Stromal Cell-Derived Factor-1 (SDF-1).
Missing: Provasculon's Product Demo & Case Studies
Promote your product offering to tech buyers.
Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.
Missing: Provasculon's Product & Differentiators
Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).
Provasculon Frequently Asked Questions (FAQ)
When was Provasculon founded?
Provasculon was founded in 2007.
Where is Provasculon's headquarters?
Provasculon's headquarters is located at 14 Cambridge Center, Cambridge.
What is Provasculon's latest funding round?
Provasculon's latest funding round is Unattributed VC.
How much did Provasculon raise?
Provasculon raised a total of $6M.
Who are the investors of Provasculon?
Investors of Provasculon include Broadview Ventures, Biogen Idec New Ventures, Partners Innovation Fund and Partnersnnovation Fund.
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.